Simulation Study of the Effects of Interstitial Fluid Pressure and Blood Flow Velocity on Transvascular Transport of Nanoparticles in Tumor Microenvironment
Overview
Affiliations
Background And Objective: Although nanoparticle preparations have great potential in the treatment of tumors, nanoparticle preparations have not achieved the desired therapeutic effect. The reason is that the abnormal tumor microenvironment prevents nanoparticles from effective concentrating and reaching tumor area. Therefore, it's very necessary to better understand the effect of the abnormal tumor microenvironment on the transvascular transport of nanoparticles to overcome this critical problem.
Methods: In this paper, a tumor abnormal vascular-interstitial model was established, and the transvascular transport process of nanoparticles was simulated in the model by computational fluid dynamics (CFD) modeling.
Results: The simulation results showed that the transport efficiency of nanoparticles decreased with increasing interstitial fluid pressure (IFP), and nanoparticles could not cross the blood vessel wall when the IFP approached the blood vessel wall pressure. Interestingly, the transport efficiency of nanoparticles first increased with blood flow velocity, and then decreased with blood flow velocity.
Conclusions: The results showed that with the continuous malignant development of tumors, the ability of nanoparticles to passively diffuse has almost disappeared. The enhanced permeability and retention (EPR) effect of the nanoparticles disappeared with the disappearance of the pressure gradient inside the tumor. These results provided guidance for future research on the vascular transport pathways and mechanisms of nanoparticles.
Wang H, Bo W, Feng X, Zhang J, Li G, Chen Y Int J Nanomedicine. 2024; 19:5581-5603.
PMID: 38882543 PMC: 11177867. DOI: 10.2147/IJN.S460844.
Shabbir F, Mujeeb A, Jawed S, Haider Khan A, Shakeel C Sci Rep. 2024; 14(1):1764.
PMID: 38242952 PMC: 10798967. DOI: 10.1038/s41598-024-52292-0.
Experimental Methods for the Biological Evaluation of Nanoparticle-Based Drug Delivery Risks.
Pandey R, Vidic J, Mukherjee R, Chang C Pharmaceutics. 2023; 15(2).
PMID: 36839932 PMC: 9959606. DOI: 10.3390/pharmaceutics15020612.
Polymeric Carriers for Delivery of RNA Cancer Therapeutics.
Miron-Barroso S, Correia J, Frampton A, Lythgoe M, Clark J, Tookman L Noncoding RNA. 2022; 8(4).
PMID: 36005826 PMC: 9412371. DOI: 10.3390/ncrna8040058.
An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment.
Sharifi M, Cho W, Ansariesfahani A, Tarharoudi R, Malekisarvar H, Sari S Cancers (Basel). 2022; 14(12).
PMID: 35740534 PMC: 9220781. DOI: 10.3390/cancers14122868.